Rationale for Catheter Directed Therapy in Pulmonary Embolism

Overview

Journal Cardiovasc Diagn Ther

Publisher AME Publishing Company

Specialty Cardiology & Vascular Diseases

Date 2018 Feb 6

PMID 29399536

Citations 8

Authors

Sailen G Naidu

Martha-Gracia Knuttinen

J Scott Kriegshauser

William G Eversman

Rahmi Oklu

Affiliations

Soon will be listed here.

Abstract

Pulmonary embolism (PE) is a widespread health concern associated with major morbidity and mortality. Catheter directed therapy (CDT) has emerged as a treatment option for acute PE adding to the current potential options of systemic thrombolysis or anticoagulation. The purpose of this review is to understand the rationale and indications for CDT in patients with PE. While numerous studies have shown the benefits of systemic thrombolysis compared to standard anticoagulation, these are balanced by the increased risk of major bleeding. With this in mind, CDT has the potential to offer the benefits of systemic thrombolysis and in theory, a reduced risk of bleeding. This article will review current treatment guidelines in both massive and submassive PE evaluating both short and long term benefits. The role of CDT will be highlighted, with an emphasis on efficacy and safety.

Citing Articles

Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis.

Planer D, Yanko S, Matok I, Paltiel O, Zmiro R, Rotshild V CMAJ. 2023; 195(24):E833-E843.

PMID: 37336568 PMC: 10281204. DOI: 10.1503/cmaj.220960.

Advances in Percutaneous Management of Pulmonary Embolism.

Kerrigan J, Morse M, Haddad E, Willers E, Ramaiah C Int J Angiol. 2022; 31(3):203-212.

PMID: 36157096 PMC: 9507563. DOI: 10.1055/s-0042-1756174.

How we dealt with the double whammy! Acute pulmonary embolism with abdominal aortic clot and renal infarcts.

Roman S, Rushdy A, Ashkar H, Millet C, Mekheal E, Abuarqob S Radiol Case Rep. 2022; 17(10):3816-3819.

PMID: 35965922 PMC: 9372741. DOI: 10.1016/j.radcr.2022.07.054.

EkoSonic™ Endovascular System-Directed Thrombolysis in a Patient With COVID-19 Infection Presenting With Bilateral Large Pulmonary Embolism Causing Right Ventricular Strain: A Case Report.

Khan Z, Gupta A, Pabani U, Lohano S, Mlawa G Cureus. 2022; 14(1):e21011.

PMID: 35154983 PMC: 8818291. DOI: 10.7759/cureus.21011.

Catheter-Directed Thrombectomy for Pulmonary Embolism in the Setting of Acute Stroke.

Hoster C, Herring M, Planek M, Attanasio S Cureus. 2020; 12(8):e9874.

PMID: 32963914 PMC: 7500746. DOI: 10.7759/cureus.9874.

References

Fuller T, Paprzycki C, Zubair M, Hussain L, Kuhn B, Recht M . Initial Experiences with Endovascular Management of Submassive Pulmonary Embolism: Is It Safe?. Ann Vasc Surg. 2016; 38:158-163. DOI: 10.1016/j.avsg.2016.09.002. View

Piazza G, Hohlfelder B, Jaff M, Ouriel K, Engelhardt T, Sterling K . A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv. 2015; 8(10):1382-1392. DOI: 10.1016/j.jcin.2015.04.020. View

. Venous thromboembolism in adult hospitalizations - United States, 2007-2009. MMWR Morb Mortal Wkly Rep. 2012; 61(22):401-4. View

Avgerinos E, Liang N, El-Shazly O, Toma C, Singh M, Makaroun M . Improved early right ventricular function recovery but increased complications with catheter-directed interventions compared with anticoagulation alone for submassive pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2016; 4(3):268-75. PMC: 7151648. DOI: 10.1016/j.jvsv.2015.11.003. View

Klok F, van der Hulle T, den Exter P, Lankeit M, Huisman M, Konstantinides S . The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 2014; 28(6):221-6. DOI: 10.1016/j.blre.2014.07.003. View

Fiumara K, Kucher N, Fanikos J, Goldhaber S . Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol. 2005; 97(1):127-9. DOI: 10.1016/j.amjcard.2005.07.117. View

Lee K, Cha A, Kumar M, Rezayat C, Sales C . Catheter-directed, ultrasound-assisted thrombolysis is a safe and effective treatment for pulmonary embolism, even in high-risk patients. J Vasc Surg Venous Lymphat Disord. 2017; 5(2):165-170. DOI: 10.1016/j.jvsv.2016.10.075. View

Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M . Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol. 2012; 111(2):273-7. DOI: 10.1016/j.amjcard.2012.09.027. View

Stevinson B, Hernandez-Nino J, Rose G, Kline J . Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. Eur Heart J. 2007; 28(20):2517-24. DOI: 10.1093/eurheartj/ehm295. View

10.

Lou B, Wang L, Chen Y . A meta-analysis of efficacy and safety of catheter-directed interventions in submassive pulmonary embolism. Eur Rev Med Pharmacol Sci. 2017; 21(1):184-198. View

11.

Konstantinides S . 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014; 35(45):3145-6. DOI: 10.1093/eurheartj/ehu393. View

12.

Kearon C, Akl E, Ornelas J, Blaivas A, Jimenez D, Bounameaux H . Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016; 149(2):315-352. DOI: 10.1016/j.chest.2015.11.026. View

13.

Grifoni S, Vanni S, Magazzini S, Olivotto I, Conti A, Zanobetti M . Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. Arch Intern Med. 2006; 166(19):2151-6. DOI: 10.1001/archinte.166.19.2151. View

14.

Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W . Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002; 347(15):1143-50. DOI: 10.1056/NEJMoa021274. View

15.

Wan S, Quinlan D, Agnelli G, Eikelboom J . Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004; 110(6):744-9. DOI: 10.1161/01.CIR.0000137826.09715.9C. View

16.

Pengo V, Lensing A, Prins M, Marchiori A, Davidson B, Tiozzo F . Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004; 350(22):2257-64. DOI: 10.1056/NEJMoa032274. View

17.

Kuo W, Banerjee A, Kim P, DeMarco Jr F, Levy J, Facchini F . Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results From a Prospective Multicenter Registry. Chest. 2015; 148(3):667-673. DOI: 10.1378/chest.15-0119. View

18.

Jaff M, McMurtry M, Archer S, Cushman M, Goldenberg N, Goldhaber S . Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011; 123(16):1788-830. DOI: 10.1161/CIR.0b013e318214914f. View

19.

Zarghouni M, Charles H, Maldonado T, Deipolyi A . Catheter-directed interventions for pulmonary embolism. Cardiovasc Diagn Ther. 2017; 6(6):651-661. PMC: 5220195. DOI: 10.21037/cdt.2016.11.15. View

20.

Sista A, Kuo W, Schiebler M, Madoff D . Stratification, Imaging, and Management of Acute Massive and Submassive Pulmonary Embolism. Radiology. 2017; 284(1):5-24. DOI: 10.1148/radiol.2017151978. View